Medicinal cannabis guidelines (FOI)
Medicinal cannabis guidelines (FOI)Produced by the Freedom of Information office
Authored by States of Jersey and published on 27 September 2018.
With all Bedrocan cannabis products and Tilray's oral solutions and capsules only (not their extensive list of flower these extracts are created with) being accepted by our Misuse of Drugs Advisory Council (MDAC), Chief Pharmacist and both previous and current health ministers, can you please provide the exact guidelines and Good Manufacturing Practice (GMP) these companies and their products must adhere to, to be accepted for rescheduling and prescription?
The products must be manufactured in accordance with the principles of Good Manufacturing Practice (GMP), as laid down by Commission Directive 2003/94/EC, by a manufacturer holding a GMP certificate issued by a national competent authority of the European Union and listed in the EudraGMDP database referred to in Article 111(6) of Directive 2001/83/EC of the European Parliament and Article 80(6) of Directive 2001/82/EC of the European Parliament.
These guidelines are publically available and can be found via a web search. Therefore, this information is accessible by other means and exempt under Article 23 of the Freedom of Information (Jersey) Law 2011.
Article 23 Information accessible to applicant by other means
(1) Information is absolutely exempt information if it is reasonably available to the applicant, otherwise than under this Law, whether or not free of charge.
(2) A scheduled public authority that refuses an application for information on this ground must make reasonable efforts to inform the applicant where the applicant may obtain the information.